Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Healthtrust
Argus Health
UBS
Teva
US Department of Justice
Mallinckrodt
Federal Trade Commission
Chubb
US Army

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,259,315

« Back to Dashboard

Summary for Patent: 4,259,315

Title: Controlled release potassium dosage form
Abstract:Pharmaceutical compositions for treating potassium deficiency in monogastric animals comprising gelatin capsules containing mixture comprised of controlled release form of microencapsulated potassium salt and hydrophilic surfactant are disclosed.
Inventor(s): Lippmann; Irwin (Richmond, VA), Popli; Shankar D. (Richmond, VA), Miller; Larry G. (Richmond, VA), Bell; Louis G. (Richmond, VA)
Assignee: A. H. Robins Company, Inc. (Richmond, VA)
Application Number:06/159,335
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Use;

No matches for this query

International Patent Family for Patent: 4,259,315

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
France2484254► Subscribe
United Kingdom2077587► Subscribe
Germany3100808► Subscribe
Canada1135624► Subscribe
Switzerland648206► Subscribe
Israel61817► Subscribe
Australia6589880► Subscribe
Belgium886973► Subscribe
Australia544965► Subscribe
Italy8167071► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
McKesson
Accenture
Healthtrust
Queensland Health
Cipla
Cantor Fitzgerald
Harvard Business School
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot